Brown-Forman vs CVS
Two tickers, one decision framework. Instead of vibes, put both names through the same quality → valuation → thesis-breaks → timing process and let the weaker story drop.
Key facts — quick answer
- BF-B = Brown-Forman (US) · CVS = CVS (US).
- Snapshot 2026-08-29: BF-B $27.28 · signal LONG · ret -46.4% ‖ CVS $92.92 · signal LONG · ret +40.0%.
- The one with the wider gap between price and its valuation ceiling — at equal quality — usually wins the slot.
Snapshot comparison (2026-08-29)
| BF-B | CVS | |
|---|---|---|
| Company | Brown-Forman | CVS |
| Market | 🇺🇸 US | 🇺🇸 US |
| Sector | Consumer Staples | Healthcare |
| Price | $27.28 | $92.92 |
| Signal | LONG · +1.0% | LONG · +40.0% |
| Total return | -46.4% | +40.0% |
Decide it with the calculator
Run both names through the free intrinsic value calculator — the one with the wider gap between price and ceiling on equal quality usually wins the slot.
Open both briefs
Get more Balance Labs in your Google results
Add balancelabs.app as a Preferred Source on Google.
← All guides · Home · Data snapshot 2026-08-29 · Not investment advice.